IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 348 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $159,221,447 | +109495.5% | 3,510,173 | -0.9% | 8.52% | +11.7% |
Q2 2023 | $145,281 | +14.8% | 3,540,858 | -0.0% | 7.63% | +10.7% |
Q1 2023 | $126,557 | -5.4% | 3,541,046 | -0.0% | 6.89% | -3.3% |
Q4 2022 | $133,749 | -99.9% | 3,541,136 | +30.0% | 7.12% | +34.4% |
Q3 2022 | $120,438,000 | +19.3% | 2,722,988 | -0.1% | 5.30% | +28.4% |
Q2 2022 | $100,945,000 | -6.8% | 2,726,778 | -6.8% | 4.13% | +17.9% |
Q1 2022 | $108,346,000 | – | 2,925,102 | – | 3.50% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |